We are convinced that the Medical On Group Investment strong> company has everything necessary to meet the ever-growing needs of global health care in the face of population growth and an increasing proportion of the aging population.
We are confident that we are clearly The formulated mission, strategy and highly developed culture will allow us to create long-term values for the company, shareholders, investors and society as a whole.
Our research and development strategy is aimed at strengthening our positions in the company' s traditionally strong areas of healthcare, including oncology, cardiovascular diseases, ophthalmology, biological products and neurology.
As well as developing innovative areas such as immuno-oncology , prevention of aging, regenerative medicine and infectious diseases.
In 2014, the company "Medical On Group Investment" strong> in Russia began implementing an investment strategy, the main areas of which are localization of production, educational programs with leading universities, support for Russian research projects.
Объединяя их, инвестиционная стратегия "Medical On Group Investment" It is the company' s contribution to the development of Russian medical innovations, the modernization of the pharmaceutical industry, the improvement of the quality of medical care, the increase in life expectancy and the improvement of Russian health and well-being.